Meeder Asset Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Meeder Asset Management’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-247	Closed	-$2K	–	2610
2020 Q1	$2K	Sell	247 -14	-5%	-$112	﹤0.01%	2137
2019 Q4	$3K	Sell	261 -324	-55%	-$2.36K	﹤0.01%	1967
2019 Q3	$2K	Buy	585 +331	+130%	+$2.68K	﹤0.01%	2012
2019 Q2	$4K	Buy	254 +204	+408%	+$3.69K	﹤0.01%	1761
2019 Q1	$1K	Sell	50 -351	-88%	-$8.8K	﹤0.01%	1659
2018 Q4	$7K	Buy	+401	New	+$8.19K	﹤0.01%	1346
2017 Q3	–	Sell	-309	Closed	-$29K	–	1801
2017 Q2	$29K	Buy	309 +282	+1,044%	+$17.3K	﹤0.01%	761
2017 Q1	$2K	Sell	27 -187	-87%	-$11.4K	﹤0.01%	1431
2016 Q4	$10K	Buy	+214	New	+$7.53K	﹤0.01%	761
2016 Q3	–	Sell	-6,132	Closed	-$84K	–	991
2016 Q2	$84K	Buy	+6,132	New	+$89.6K	0.01%	680

Other funds holding CLVS

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Meeder Asset Management's CLVS Position: Q2 2020 in Review

Meeder Asset Management sold out of Clovis Oncology, Inc. (CLVS) in Q2 2020, closing a stake of 247 shares — an estimated $2K sold.

Meeder Asset Management first reported a position in CLVS in Q2 2016 and held it in 10 quarters. The position peaked at $84K in Q2 2016. 158 funds tracked by Wall St. Rank hold CLVS as of Q2 2020.

Meeder Asset Management reported no remaining Clovis Oncology, Inc. position as of Q2 2020 after selling out during the quarter.
Meeder Asset Management sold 247 Clovis Oncology, Inc. shares in Q2 2020, an estimated $2K.
Meeder Asset Management first reported a position in Clovis Oncology, Inc. in Q2 2016 and held it in 10 quarters.
Meeder Asset Management's Clovis Oncology, Inc. position peaked at $84K in Q2 2016.
158 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q2 2020.

Based on Meeder Asset Management's 13F filing for Q2 2020, filed 11 Aug 2020.